The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis

Lignende værker

• The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
  af: Miravitlles M, et al.
  Udgivet: (2016-08-01)
• Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
  af: D’Urzo, Anthony D, et al.
  Udgivet: (2019)
• The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies
  af: Jones, Paul W., et al.
  Udgivet: (2016)
• Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
  af: Bateman, Eric D., et al.
  Udgivet: (2015)
• Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
  af: Dave Singh, et al.
  Udgivet: (2017-05-01)